Pharmacokinetic parameters (mean ± SD) obtained for flubendazole (FLBZ) after its administration (5 mg/kg) as different formulations to uninfected jirds: Cyclodextrin-based (FLBZ-CDoral or FLBZ-CDsc) and Tween-based (FLBZ-TWEEN) formulations.

Cmax: peak plasma concentration; Tmax: time to peak plasma concentration; AUC0-LOQ: area under the concentration vs. time curve from 0 up to the limit of quantification. Different letters indicate statistically significant differences (P.